Lifibrol: first member of a new class of

Author： Scharnagl H.   Mrz W.   Wieland H.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.5, 1997-05, pp. : 583-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro skin permeation of Sinitrodil, a member of a new class of nitrovasodilator drugs

By Minghetti P.   Casiraghi A.   Montanari L.   Monzani M.V.  

European Journal of Pharmaceutical Sciences, Vol. 7, Iss. 3, 1999-02 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management

By Cantor L.B.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 721-731

Informa Healthcare

Access to resources Recommend Favorite

Caspofungin: first approved agent in a new class of antifungals

By Johnson Melissa D   Perfect John R  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 807-823

Informa Healthcare

Access to resources Recommend Favorite

Polymorphism and preformulation studies of lifibrol

By Franceschini G.   Burger A.   Lettenbichler A.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 49, Iss. 1, 2000-01 ,pp. : 65-72

Elsevier

Access to resources Recommend Favorite

Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives

By Oh Byung-Hee  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2839-2849

Informa Healthcare

Access to resources Recommend Favorite